^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners

TEST:
TheraMap Test

Type:
Laboratory Developed Test

Details

Evidence
TheraMap is a hybrid capture DNA- and RNA-based test that detects SNV, INDELs, Copy Number Variants (CNV), and fusions in solid tumors. TheraMap is validated for all solid tumor types and includes sequencing over 500 genes identified as relevant to cancer treatment, relevant gene fusion events, including NTRK fusions, as well as the important microsatellite instability (MSI) and tumor mutational burden (TMB) biomarkers.
Cancer:
Solid Tumor
Gene:
ABL2 (ABL Proto-Oncogene 2, Non-Receptor Tyrosine Kinase), AKT1 (V-akt murine thymoma viral oncogene homolog 1), ARAF (A-Raf Proto-Oncogene), ARID2 (AT-Rich Interaction Domain 2), ASXL1 (ASXL Transcriptional Regulator 1), AURKA (Aurora kinase A)
See More ...
Method:
Next-Generation Sequencing (NGS)